Skip to main content
. 2018 Sep 13;31(2):97–104. doi: 10.1038/s41443-018-0075-x

Fig. 5.

Fig. 5

Immunohistochemical staining of vWF. a Control group. b Diabetic ED group. c Epalrestat-treated group. d Statistical chart of the vWF density among groups; the arrows indicate the endothelium of cavernosum expressing vWF. *P < 0.01 compared to the normal control group; #P < 0.05 compared to the diabetic group. DED diabetic group, Epal epalrestat-treated group, vWF von Willebrand factor. Scale bars = 100 μm